Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Danielle Wilhelmsen"'
Autor:
Glenn S. Gerhard, Bethany Davis, Xiumei Wu, Amanda Hanson, Danielle Wilhelmsen, Ignazio S. Piras, Christopher D. Still, Xin Chu, Anthony T. Petrick, Johanna K. DiStefano
Publikováno v:
Biochemistry and Biophysics Reports, Vol 22, Iss , Pp - (2020)
We previously reported dysregulated expression of liver-derived messenger RNA (mRNA) and long noncoding RNA (lncRNA) in patients with advanced fibrosis resulting from nonalcoholic fatty liver disease (NAFLD). Here we sought to identify changes in mRN
Externí odkaz:
https://doaj.org/article/d90250de239646099a9ee0ad54099ab8
Autor:
Glenn S Gerhard, Amanda Hanson, Danielle Wilhelmsen, Ignazio S Piras, Christopher D Still, Xin Chu, Anthony T Petrick, Johanna K DiStefano
Publikováno v:
PLoS ONE, Vol 14, Iss 7, p e0219764 (2019)
Factors governing the development of liver fibrosis in nonalcoholic steatohepatitis (NASH) are only partially understood. We recently identified adipocyte enhancer binding protein 1 (AEBP1) as a member of a core set of dysregulated fibrosis-specific
Externí odkaz:
https://doaj.org/article/7d9a7df140ee4a8eb0ebdc0803ef121f
Publikováno v:
Non-Coding RNA, Vol 4, Iss 3, p 18 (2018)
Nonalcoholic fatty liver disease (NAFLD) encompasses a spectrum of conditions ranging from hepatic steatosis to inflammation (nonalcoholic steatohepatitis or NASH) with or without fibrosis, in the absence of significant alcohol consumption. The prese
Externí odkaz:
https://doaj.org/article/3fd4dd26375e447eab647e2ef863b12e
Publikováno v:
Diabetes. 68
Type 2 diabetes (T2D) and obesity are associated with fat accumulation in the liver, which is commonly diagnosed as nonalcoholic fatty liver disease (NAFLD). Not only do individuals with T2D have an increased risk of developing the disease, but patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab72679b6ef145f708d9b5a42d9bbeeb
https://doi.org/10.2337/db19-2119-p
https://doi.org/10.2337/db19-2119-p
Autor:
Xiumei Wu, Xin Chu, Danielle Wilhelmsen, Christopher D. Still, Bethany Davis, Glenn S. Gerhard, Ignazio S. Piras, Johanna K. DiStefano, Anthony T. Petrick, Amanda Hanson
Publikováno v:
Biochemistry and Biophysics Reports
Biochemistry and Biophysics Reports, Vol 22, Iss, Pp-(2020)
Biochemistry and Biophysics Reports, Vol 22, Iss, Pp-(2020)
We previously reported dysregulated expression of liver-derived messenger RNA (mRNA) and long noncoding RNA (lncRNA) in patients with advanced fibrosis resulting from nonalcoholic fatty liver disease (NAFLD). Here we sought to identify changes in mRN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80ed5de93efb8007c6fce7c93f474acb
https://pubmed.ncbi.nlm.nih.gov/32258441
https://pubmed.ncbi.nlm.nih.gov/32258441
Publikováno v:
Non-Coding RNA
Non-Coding RNA, Vol 4, Iss 3, p 18 (2018)
Non-Coding RNA, Vol 4, Iss 3, p 18 (2018)
Nonalcoholic fatty liver disease (NAFLD) encompasses a spectrum of conditions ranging from hepatic steatosis to inflammation (nonalcoholic steatohepatitis or NASH) with or without fibrosis, in the absence of significant alcohol consumption. The prese
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eacce89967cdd9df5c904c43b32ebe41
http://europepmc.org/articles/PMC6162709
http://europepmc.org/articles/PMC6162709
Autor:
Ignazio S. Piras, Johanna K. DiStefano, Anthony T. Petrick, Glenn S. Gerhard, Danielle Wilhelmsen, Christopher D. Still, Xin Chu, Amanda Hanson
Publikováno v:
Cytokine
CCL20 (CC chemokine ligand 20) is emerging as an important regulatory molecule in a pathway common to virus infection, alcoholic hepatitis, and non-alcoholic fatty liver disease (NAFLD) leading to the development of hepatic fibrosis. We previously ob
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd84f8ee9ccd16a86e5355f1b8c0ea03
https://doi.org/10.1016/j.cyto.2019.154789
https://doi.org/10.1016/j.cyto.2019.154789
Autor:
Amanda Hanson, Xin Chu, Ignazio S. Piras, Anthony T. Petrick, Johanna K. DiStefano, Christopher D. Still, Glenn S. Gerhard, Danielle Wilhelmsen
Publikováno v:
PLoS ONE, Vol 14, Iss 7, p e0219764 (2019)
PLoS ONE
PLoS ONE
Factors governing the development of liver fibrosis in nonalcoholic steatohepatitis (NASH) are only partially understood. We recently identified adipocyte enhancer binding protein 1 (AEBP1) as a member of a core set of dysregulated fibrosis-specific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c92b8b1c6d87d930156d21a7c0f6597a
https://doi.org/10.1371/journal.pone.0219764
https://doi.org/10.1371/journal.pone.0219764
Autor:
Gerhard, Glenn S.1, Hanson, Amanda2, Wilhelmsen, Danielle2, Piras, Ignazio S.2, Still, Christopher D.3, Chu, Xin3, Petrick, Anthony T.3, DiStefano, Johanna K.2 jdistefano@tgen.org
Publikováno v:
PLoS ONE. 7/12/2019, Vol. 14 Issue 7, p1-20. 20p.